Related Experiment Video
Updated: Jun 26, 2026

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X
A Di Monaco1, I Bruno, A Sestito
1Istituto di Cardiologia, Università Cattolica del Sacro Cuore, Roma, Italy.
Insights
Cardiac MIBG uptake abnormalities and coronary microvascular dysfunction are common in cardiac syndrome X (CSX). However, this study found no correlation between these cardiac MIBG defects and impaired coronary flow response in CSX patients.
Area of Science:
- Cardiology
- Nuclear Medicine
- Cardiovascular Imaging
Background:
- Cardiac Syndrome X (CSX) is characterized by chest pain despite normal coronary angiograms.
- Coronary microvascular dysfunction (CMD) is increasingly recognized as a key feature of CSX.
- The role of cardiac autonomic dysfunction in CSX is not fully understood.
Purpose of the Study:
- To investigate the relationship between cardiac adrenergic nerve function, assessed by (123)I-metaiodobenzylguanidine (MIBG) scintigraphy, and coronary microvascular dysfunction in patients with CSX.
- To determine if MIBG uptake abnormalities correlate with impaired coronary flow reserve in CSX.
Main Methods:
- A case-control study involving 29 patients with CSX and 20 healthy controls.
- Myocardial scintigraphy using (123)I-metaiodobenzylguanidine (MIBG) planar and SPECT imaging.
- Coronary flow response (CFR) to adenosine and cold pressor test (CPT) assessed by transthoracic Doppler echocardiography in the LAD coronary artery.
Main Results:
- 86.2% of CSX patients exhibited abnormal cardiac MIBG uptake compared to none of the controls (p<0.001).
- CSX patients had significantly lower heart/mediastinum (H/M) MIBG uptake ratio and higher defect scores than controls (p<0.001 and p=0.002, respectively).
- Coronary flow response to both adenosine and CPT was significantly reduced in CSX patients compared to controls (p<0.001 for both).
- No significant correlation was found between MIBG uptake parameters (H/M ratio, defect score) and CFR to adenosine or CPT in CSX patients (p>0.05 for all).
Conclusions:
- Patients with CSX demonstrate significant abnormalities in both cardiac adrenergic nerve function and coronary microvascular function.
- Despite the presence of both abnormalities, no direct correlation was identified between MIBG uptake defects and impaired coronary microvascular function in this CSX cohort.
- Further research is warranted to elucidate the underlying mechanisms and the clinical significance of MIBG defects in CSX.
Objective:
To assess whether abnormalities in cardiac uptake of (123)I-metaiodobenzylguanidine (MIBG) correlate with coronary microvascular dysfunction in patients with cardiac syndrome X (CSX).
Setting:
University hospital.
Patients:
29 patients (aged 59 (SD 7) years, 11 men) with typical CSX and a matched group of 20 healthy subjects (aged 56 (7) years, 8 men) were studied.
Interventions:
Planar and single photon emission computed tomography (SPECT) MIBG myocardial scintigraphy was performed in all subjects. Coronary flow response (CFR) to adenosine and to cold pressor test (CPT) in the left anterior descending (LAD) coronary artery was assessed in all CSX patients and in 12 controls by transthoracic Doppler echocardiography.
Main Outcome Measures:
Abnormalities in cardiac MIBG scintigraphy were observed in 25 CSX patients (86.2%), but in no healthy control (p<0.001). Compared to controls, CSX patients showed a lower heart/mediastinum (H/M) ratio of MIBG uptake (1.69 (0.24) vs 2.2 (0.3), p<0.001) and a higher cardiac MIBG defect score (25 (22) vs 4 (2), p = 0.002). Both CFR to adenosine (3.31 (1.1) vs 1.94 (0.6), p<0.001) and CFR to CPT (2.35 (0.5) vs 1.63 (0.4), p<0.001) were lower in CSX patients than in controls. In CSX patients, however, no correlation was found between MIBG H/M ratio and CFR to adenosine (r = 0.17; p = 0.38) and to CPT (r = -0.28; p = 0.13), as well as between MIBG uptake score in the LAD territory and CFR to adenosine (r = 0.14; p = 0.47) and to CPT (r = 0.06; p = 0.73).
Conclusion:
Our data show striking abnormalities in cardiac adrenergic nerve function and in coronary microvascular function in CSX patients. However, no significant relation between the two abnormalities was found. Further studies are needed to clarify the mechanisms and the role of MIBG defects in CSX patients.
Related Concept Videos
Pathophysiology of Heart Failure
Pathophysiology of Cardiac Performance
Heart Failure II: Pathophysiology
Cardiomyopathy VI: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
